APA (7th ed.) Citation

B, H., KH, W., ZJ, L., JA, E., J, L., ER, B., . . . R, G. (2025). Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity. EMBO molecular medicine, 17(5), 1071. https://doi.org/10.1038/s44321-025-00222-6

Chicago Style (17th ed.) Citation

B, He, et al. "Selective Tubulin-binding Drugs Induce Pericyte Phenotype Switching and Anti-cancer Immunity." EMBO Molecular Medicine 17, no. 5 (2025): 1071. https://doi.org/10.1038/s44321-025-00222-6.

MLA (9th ed.) Citation

B, He, et al. "Selective Tubulin-binding Drugs Induce Pericyte Phenotype Switching and Anti-cancer Immunity." EMBO Molecular Medicine, vol. 17, no. 5, 2025, p. 1071, https://doi.org/10.1038/s44321-025-00222-6.